Tearlab Earnings: What Investors Should Watch

Tearlab (NASDAQ:TEAR) will report earnings after markets close on Tuesday, August 13th. TearLab Corp. is an in-vitro diagnostics company. The Company develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to test for sensitive and specific biomarkers in tears at the point-of-care.

Here is your Cheat Sheet to Tearlab Earnings:

Earnings Expectations: Analysts expect earnings of $-0.12 per share on revenues of $3.48 million.

Analyst Trends:

Analysts have a neutral outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings is a loss of $0.1 and has not changed. For the current year, the average estimate is a loss of $0.42, which is better than the estimate ninety days ago.

Earnings Trends:

Here’s how Tearlab has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 0 1 2 2 4
Diluted EPS ($) -3.47 -0.44 -0.47 -0.50 0.00

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012 Mar. 31, 2013
Revenue ($) in millions 0.72 1.21 1.61 2.47
Diluted EPS ($) -0.10 -0.17 -0.13 -0.30

Past Performance:
Tearlab has beat analyst estimates 2 times in the past four quarters. This is not consistent enough to get bullish yet.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)